羟氯喹在免疫介导的风湿性疾病中的心脏效应。
The cardiac effects of hydroxychloroquine in immune-mediated rheumatologic diseases.
机构信息
In the PA program at Louisiana State University's Health Sciences Center in Shreveport, La., Emily Weidman-Evans is a professor and Mandy Porter is an instructor. The authors have disclosed no potential conflicts of interest, financial or otherwise.
出版信息
JAAPA. 2022 Apr 1;35(4):51-53. doi: 10.1097/01.JAA.0000805852.13262.54.
Hydroxychloroquine, when used to treat patients with rheumatoid arthritis or systemic lupus erythematosus, has been found to reduce cardiovascular disease (CVD). The drug also has been associated with cardiac adverse reactions such as conduction abnormalities. This article reviews the reduction of CVD and the cardiac adverse reactions associated with hydroxychloroquine.
羟氯喹在用于治疗类风湿关节炎或系统性红斑狼疮患者时，已被发现可降低心血管疾病（CVD）的风险。该药物也与传导异常等心脏不良反应有关。本文综述了羟氯喹对 CVD 的降低作用以及与该药物相关的心脏不良反应。
Zotero 插件